Abbott Laboratories's market cap is currently ―. The company's EPS TTM is $3.21; its P/E ratio is 32.40; and it has a dividend yield of 2.04%. Abbott Laboratories is scheduled to report earnings on July 18, 2024, and the estimated EPS forecast is $1.11. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 9.96B	$ 10.24B	$ 10.14B	$ 9.98B	$ 9.75B
Gross Profit	$ 5.50B	$ 5.68B	$ 5.54B	$ 5.50B	$ 5.42B
EBIT	$ 1.58B	$ 1.95B	$ 1.84B	$ 1.79B	$ 1.72B
EBITDA	$ 2.38B	$ 2.77B	$ 2.66B	$ 2.60B	$ 2.52B
Net Income Common Stockholders	$ 1.23B	$ 1.59B	$ 1.44B	$ 1.38B	$ 1.32B
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 6.65B	$ 7.28B	$ 7.05B	$ 8.15B	$ 9.53B
Total Assets	$ 72.47B	$ 73.21B	$ 72.09B	$ 73.40B	$ 73.77B
Total Debt	$ 14.59B	$ 14.68B	$ 15.53B	$ 16.85B	$ 16.90B
Net Debt	$ 7.93B	$ 7.40B	$ 8.48B	$ 8.69B	$ 7.37B
Total Liabilities	$ 33.42B	$ 34.39B	$ 34.40B	$ 35.95B	$ 36.56B
Stockholders Equity	$ 38.81B	$ 38.60B	$ 37.48B	$ 37.17B	$ 37.01B
Cash Flow	-
Free Cash Flow	$ 627.00M	$ 2.28B	$ 1.32B	$ 696.00M	$ 763.00M
Operating Cash Flow	$ 1.02B	$ 3.04B	$ 1.88B	$ 1.20B	$ 1.14B
Investing Cash Flow	$ -425.00M	$ -824.00M	$ -634.00M	$ -1.21B	$ -462.00M
Financing Cash Flow	$ -1.18B	$ -2.05B	$ -2.34B	$ -1.29B	$ -1.41B

Currency in USD

Abbott Laboratories Earnings and Revenue History

Income Statement >

Abbott Laboratories Debt to Assets

Balance Sheet >

Abbott Laboratories Cash Flow

Cash Flow >

Abbott Laboratories Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing